APO Research
Talk to an analyst

APO RESEARCH · REPORT

Mesenchymal Stem Cell Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Mesenchymal Stem Cell Drugs Industry Growth and Trends Forecast to 2032

27 December 202599 pages

Choose your research edition.

Industry ResearchMesenchymal Stem Cell Drugs Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Mesenchymal Stem Cell Drugs Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Mesenchymal Stem Cell Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mesenchymal Stem Cell Drugs Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Mesenchymal Stem Cell Drugs Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Mesenchymal Stem Cell Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Mesenchymal Stem Cell Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Mesenchymal Stem Cell Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Mesenchymal Stem Cell Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Mesenchymal Stem Cell Drugs include Anterogen, JCR Pharmaceuticals, Medipost, Pharmicell, Stempeutics, Osiris Therapeutics, CHIESI Farmaceutici and Takeda, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Mesenchymal Stem Cell Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Mesenchymal Stem Cell Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Mesenchymal Stem Cell Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Mesenchymal Stem Cell Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Mesenchymal Stem Cell Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Mesenchymal Stem Cell Drugs Market by Company

Anterogen

JCR Pharmaceuticals

Medipost

Pharmicell

Stempeutics

Osiris Therapeutics

CHIESI Farmaceutici

Takeda

Mesenchymal Stem Cell Drugs Segment by Type

Autologous Source

Allogeneic Source

Mesenchymal Stem Cell Drugs Segment by Application

Tissue Repair

Immunomodulation

Mesenchymal Stem Cell Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mesenchymal Stem Cell Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mesenchymal Stem Cell Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mesenchymal Stem Cell Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Mesenchymal Stem Cell Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Mesenchymal Stem Cell Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Autologous Source Table 2. Major Company of Allogeneic Source Table 3. Global Mesenchymal Stem Cell Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Mesenchymal Stem Cell Drugs Sales by Type (2021-2026) & (K Units) Table 5. Global Mesenchymal Stem Cell Drugs Sales Market Share in Volume by Type (2021-2026) Table 6. Global Mesenchymal Stem Cell Drugs Sales by Type (2021-2026) & (US$ Million) Table 7. Global Mesenchymal Stem Cell Drugs Sales Market Share in Value by Type (2021-2026) Table 8. Global Mesenchymal Stem Cell Drugs Price by Type (2021-2026) & (US$/Unit) Table 9. Global Mesenchymal Stem Cell Drugs Sales by Type (2027-2032) & (K Units) Table 10. Global Mesenchymal Stem Cell Drugs Sales Market Share in Volume by Type (2027-2032) Table 11. Global Mesenchymal Stem Cell Drugs Sales by Type (2027-2032) & (US$ Million) Table 12. Global Mesenchymal Stem Cell Drugs Sales Market Share in Value by Type (2027-2032) Table 13. Global Mesenchymal Stem Cell Drugs Price by Type (2027-2032) & (US$/Unit) Table 14. North America Mesenchymal Stem Cell Drugs Sales by Type (2021-2026) & (K Units) Table 15. North America Mesenchymal Stem Cell Drugs Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Mesenchymal Stem Cell Drugs Sales by Type (2021-2026) & (K Units) Table 17. Europe Mesenchymal Stem Cell Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Mesenchymal Stem Cell Drugs Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Mesenchymal Stem Cell Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Mesenchymal Stem Cell Drugs Sales by Type (2021-2026) & (K Units) Table 21. Latin America Mesenchymal Stem Cell Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Mesenchymal Stem Cell Drugs Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Mesenchymal Stem Cell Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Mesenchymal Stem Cell Drugs Industry Trends Table 25. Mesenchymal Stem Cell Drugs Industry Drivers Table 26. Mesenchymal Stem Cell Drugs Industry Opportunities and Challenges Table 27. Mesenchymal Stem Cell Drugs Industry Restraints Table 28. Global Mesenchymal Stem Cell Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Mesenchymal Stem Cell Drugs Revenue Market Share by Company (2021-2026) Table 30. Global Mesenchymal Stem Cell Drugs Sales by Company (2021-2026) & (K Units) Table 31. Global Mesenchymal Stem Cell Drugs Sales Share by Company (2021-2026) Table 32. Global Mesenchymal Stem Cell Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Mesenchymal Stem Cell Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Mesenchymal Stem Cell Drugs Major Company Production Sites and Headquarters Table 35. Global Mesenchymal Stem Cell Drugs Company, Product Type & Application Table 36. Global Mesenchymal Stem Cell Drugs Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Mesenchymal Stem Cell Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Mesenchymal Stem Cell Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Mesenchymal Stem Cell Drugs Sales by Region (2021-2026) & (K Units) Table 41. Global Mesenchymal Stem Cell Drugs Sales Market Share in Volume by Region (2021-2026) Table 42. Global Mesenchymal Stem Cell Drugs Sales by Region (2021-2026) & (US$ Million) Table 43. Global Mesenchymal Stem Cell Drugs Sales Market Share in Value by Region (2021-2026) Table 44. Global Mesenchymal Stem Cell Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Mesenchymal Stem Cell Drugs Sales by Region (2027-2032) & (K Units) Table 46. Global Mesenchymal Stem Cell Drugs Sales Market Share in Volume by Region (2027-2032) Table 47. Global Mesenchymal Stem Cell Drugs Sales by Region (2027-2032) & (US$ Million) Table 48. Global Mesenchymal Stem Cell Drugs Sales Market Share in Value by Region (2027-2032) Table 49. Global Mesenchymal Stem Cell Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Mesenchymal Stem Cell Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Mesenchymal Stem Cell Drugs Sales by Application (2021-2026) & (K Units) Table 52. Global Mesenchymal Stem Cell Drugs Sales Market Share in Volume by Application (2021-2026) Table 53. Global Mesenchymal Stem Cell Drugs Sales by Application (2021-2026) & (US$ Million) Table 54. Global Mesenchymal Stem Cell Drugs Sales Market Share in Value by Application (2021-2026) Table 55. Global Mesenchymal Stem Cell Drugs Price by Application (2021-2026) & (US$/Unit) Table 56. Global Mesenchymal Stem Cell Drugs Sales by Application (2027-2032) & (K Units) Table 57. Global Mesenchymal Stem Cell Drugs Sales Market Share in Volume by Application (2027-2032) Table 58. Global Mesenchymal Stem Cell Drugs Sales by Application (2027-2032) & (US$ Million) Table 59. Global Mesenchymal Stem Cell Drugs Sales Market Share in Value by Application (2027-2032) Table 60. Global Mesenchymal Stem Cell Drugs Price by Application (2027-2032) & (US$/Unit) Table 61. North America Mesenchymal Stem Cell Drugs Sales by Application (2021-2026) & (K Units) Table 62. North America Mesenchymal Stem Cell Drugs Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Mesenchymal Stem Cell Drugs Sales by Application (2021-2026) & (K Units) Table 64. Europe Mesenchymal Stem Cell Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Mesenchymal Stem Cell Drugs Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Mesenchymal Stem Cell Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Mesenchymal Stem Cell Drugs Sales by Application (2021-2026) & (K Units) Table 68. Latin America Mesenchymal Stem Cell Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Mesenchymal Stem Cell Drugs Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Mesenchymal Stem Cell Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Anterogen Company Information Table 72. Anterogen Business Overview Table 73. Anterogen Mesenchymal Stem Cell Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Anterogen Mesenchymal Stem Cell Drugs Product Portfolio Table 75. Anterogen Recent Development Table 76. JCR Pharmaceuticals Company Information Table 77. JCR Pharmaceuticals Business Overview Table 78. JCR Pharmaceuticals Mesenchymal Stem Cell Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. JCR Pharmaceuticals Mesenchymal Stem Cell Drugs Product Portfolio Table 80. JCR Pharmaceuticals Recent Development Table 81. Medipost Company Information Table 82. Medipost Business Overview Table 83. Medipost Mesenchymal Stem Cell Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Medipost Mesenchymal Stem Cell Drugs Product Portfolio Table 85. Medipost Recent Development Table 86. Pharmicell Company Information Table 87. Pharmicell Business Overview Table 88. Pharmicell Mesenchymal Stem Cell Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Pharmicell Mesenchymal Stem Cell Drugs Product Portfolio Table 90. Pharmicell Recent Development Table 91. Stempeutics Company Information Table 92. Stempeutics Business Overview Table 93. Stempeutics Mesenchymal Stem Cell Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Stempeutics Mesenchymal Stem Cell Drugs Product Portfolio Table 95. Stempeutics Recent Development Table 96. Osiris Therapeutics Company Information Table 97. Osiris Therapeutics Business Overview Table 98. Osiris Therapeutics Mesenchymal Stem Cell Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Osiris Therapeutics Mesenchymal Stem Cell Drugs Product Portfolio Table 100. Osiris Therapeutics Recent Development Table 101. CHIESI Farmaceutici Company Information Table 102. CHIESI Farmaceutici Business Overview Table 103. CHIESI Farmaceutici Mesenchymal Stem Cell Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. CHIESI Farmaceutici Mesenchymal Stem Cell Drugs Product Portfolio Table 105. CHIESI Farmaceutici Recent Development Table 106. Takeda Company Information Table 107. Takeda Business Overview Table 108. Takeda Mesenchymal Stem Cell Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Takeda Mesenchymal Stem Cell Drugs Product Portfolio Table 110. Takeda Recent Development Table 111. North America Mesenchymal Stem Cell Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. North America Mesenchymal Stem Cell Drugs Sales by Country (2021-2026) & (K Units) Table 113. North America Mesenchymal Stem Cell Drugs Sales Market Share by Country (2021-2026) Table 114. North America Mesenchymal Stem Cell Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 115. North America Mesenchymal Stem Cell Drugs Sales Market Share Forecast by Country (2027-2032) Table 116. North America Mesenchymal Stem Cell Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. North America Mesenchymal Stem Cell Drugs Market Size by Country (2021-2026) & (US$ Million) Table 118. North America Mesenchymal Stem Cell Drugs Market Share by Country (2021-2026) Table 119. North America Mesenchymal Stem Cell Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. North America Mesenchymal Stem Cell Drugs Market Share Forecast by Country (2027-2032) Table 121. Europe Mesenchymal Stem Cell Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Europe Mesenchymal Stem Cell Drugs Sales by Country (2021-2026) & (K Units) Table 123. Europe Mesenchymal Stem Cell Drugs Sales Market Share by Country (2021-2026) Table 124. Europe Mesenchymal Stem Cell Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 125. Europe Mesenchymal Stem Cell Drugs Sales Market Share Forecast by Country (2027-2032) Table 126. Europe Mesenchymal Stem Cell Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Europe Mesenchymal Stem Cell Drugs Market Size by Country (2021-2026) & (US$ Million) Table 128. Europe Mesenchymal Stem Cell Drugs Market Share by Country (2021-2026) Table 129. Europe Mesenchymal Stem Cell Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Europe Mesenchymal Stem Cell Drugs Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Mesenchymal Stem Cell Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Mesenchymal Stem Cell Drugs Sales by Country (2021-2026) & (K Units) Table 133. Asia-Pacific Mesenchymal Stem Cell Drugs Sales Market Share by Country (2021-2026) Table 134. Asia-Pacific Mesenchymal Stem Cell Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 135. Asia-Pacific Mesenchymal Stem Cell Drugs Sales Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Mesenchymal Stem Cell Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Mesenchymal Stem Cell Drugs Market Size by Country (2021-2026) & (US$ Million) Table 138. Asia-Pacific Mesenchymal Stem Cell Drugs Market Share by Country (2021-2026) Table 139. Asia-Pacific Mesenchymal Stem Cell Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Asia-Pacific Mesenchymal Stem Cell Drugs Market Share Forecast by Country (2027-2032) Table 141. Latin America Mesenchymal Stem Cell Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Latin America Mesenchymal Stem Cell Drugs Sales by Country (2021-2026) & (K Units) Table 143. Latin America Mesenchymal Stem Cell Drugs Sales Market Share by Country (2021-2026) Table 144. Latin America Mesenchymal Stem Cell Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 145. Latin America Mesenchymal Stem Cell Drugs Sales Market Share Forecast by Country (2027-2032) Table 146. Latin America Mesenchymal Stem Cell Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Latin America Mesenchymal Stem Cell Drugs Market Size by Country (2021-2026) & (US$ Million) Table 148. Latin America Mesenchymal Stem Cell Drugs Market Share by Country (2021-2026) Table 149. Latin America Mesenchymal Stem Cell Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Latin America Mesenchymal Stem Cell Drugs Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Mesenchymal Stem Cell Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Mesenchymal Stem Cell Drugs Sales by Country (2021-2026) & (K Units) Table 153. Middle East and Africa Mesenchymal Stem Cell Drugs Sales Market Share by Country (2021-2026) Table 154. Middle East and Africa Mesenchymal Stem Cell Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 155. Middle East and Africa Mesenchymal Stem Cell Drugs Sales Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Mesenchymal Stem Cell Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Mesenchymal Stem Cell Drugs Market Size by Country (2021-2026) & (US$ Million) Table 158. Middle East and Africa Mesenchymal Stem Cell Drugs Market Share by Country (2021-2026) Table 159. Middle East and Africa Mesenchymal Stem Cell Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Middle East and Africa Mesenchymal Stem Cell Drugs Market Share Forecast by Country (2027-2032) Table 161. Key Raw Materials Table 162. Raw Materials Key Suppliers Table 163. Mesenchymal Stem Cell Drugs Distributors List Table 164. Mesenchymal Stem Cell Drugs Customers List Table 165. Research Programs/Design for This Report Table 166. Authors List of This Report Table 167. Secondary Sources Table 168. Primary Sources List of Figures Figure 1. Mesenchymal Stem Cell Drugs Image Figure 2. Global Mesenchymal Stem Cell Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mesenchymal Stem Cell Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Mesenchymal Stem Cell Drugs Sales (2021-2032) & (K Units) Figure 5. Autologous Source Image Figure 6. Global Autologous Source Sales YoY Growth (2021-2032) & (K Units) Figure 7. Allogeneic Source Image Figure 8. Global Allogeneic Source Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Mesenchymal Stem Cell Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Mesenchymal Stem Cell Drugs Market Share by Type 2025 VS 2032 Figure 11. North America Mesenchymal Stem Cell Drugs Sales Market Share in Volume by Type in 2025 Figure 12. North America Mesenchymal Stem Cell Drugs Sales Market Share in Value by Type in 2025 Figure 13. Europe Mesenchymal Stem Cell Drugs Sales Market Share in Volume by Type in 2025 Figure 14. Europe Mesenchymal Stem Cell Drugs Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Mesenchymal Stem Cell Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Mesenchymal Stem Cell Drugs Sales Market Share in Value by Type in 2025 Figure 17. Latin America Mesenchymal Stem Cell Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Mesenchymal Stem Cell Drugs Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Mesenchymal Stem Cell Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Mesenchymal Stem Cell Drugs Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Mesenchymal Stem Cell Drugs Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Tissue Repair Image Figure 24. Global Tissue Repair Sales YoY Growth (2021-2032) & (K Units) Figure 25. Immunomodulation Image Figure 26. Global Immunomodulation Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Mesenchymal Stem Cell Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Mesenchymal Stem Cell Drugs Market Share by Application 2025 VS 2032 Figure 29. North America Mesenchymal Stem Cell Drugs Sales Market Share in Volume by Application in 2025 Figure 30. North America Mesenchymal Stem Cell Drugs Sales Market Share in Value by Application in 2025 Figure 31. Europe Mesenchymal Stem Cell Drugs Sales Market Share in Volume by Application in 2025 Figure 32. Europe Mesenchymal Stem Cell Drugs Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Mesenchymal Stem Cell Drugs Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Mesenchymal Stem Cell Drugs Sales Market Share in Value by Application in 2025 Figure 35. Latin America Mesenchymal Stem Cell Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Mesenchymal Stem Cell Drugs Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Mesenchymal Stem Cell Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Mesenchymal Stem Cell Drugs Sales Market Share in Value by Application in 2025 Figure 39. North America Mesenchymal Stem Cell Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Mesenchymal Stem Cell Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Mesenchymal Stem Cell Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Mesenchymal Stem Cell Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Mesenchymal Stem Cell Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Mesenchymal Stem Cell Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Mesenchymal Stem Cell Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Mesenchymal Stem Cell Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Mesenchymal Stem Cell Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Mesenchymal Stem Cell Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Mesenchymal Stem Cell Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Mesenchymal Stem Cell Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Mesenchymal Stem Cell Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Mesenchymal Stem Cell Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Mesenchymal Stem Cell Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Mesenchymal Stem Cell Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Mesenchymal Stem Cell Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Mesenchymal Stem Cell Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Mesenchymal Stem Cell Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Mesenchymal Stem Cell Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Mesenchymal Stem Cell Drugs Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Mesenchymal Stem Cell Drugs Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Autologous Source
  • Allogeneic Source
Applications
  • Tissue Repair
  • Immunomodulation
Companies covered
  • Anterogen
  • JCR Pharmaceuticals
  • Medipost
  • Pharmicell
  • Stempeutics
  • Osiris Therapeutics
  • CHIESI Farmaceutici
  • Takeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Mesenchymal Stem Cell Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Mesenchymal Stem Cell Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Mesenchymal Stem Cell Drugs Market by Type
  6. 1.3.1 Autologous Source
  7. 1.3.2 Allogeneic Source
  8. 1.4 Global Mesenchymal Stem Cell Drugs Market Size by Type
  9. 1.4.1 Global Mesenchymal Stem Cell Drugs Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Mesenchymal Stem Cell Drugs Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Mesenchymal Stem Cell Drugs Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Mesenchymal Stem Cell Drugs Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Mesenchymal Stem Cell Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Mesenchymal Stem Cell Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Mesenchymal Stem Cell Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Mesenchymal Stem Cell Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Mesenchymal Stem Cell Drugs Industry Trends
  2. 2.2 Mesenchymal Stem Cell Drugs Industry Drivers
  3. 2.3 Mesenchymal Stem Cell Drugs Industry Opportunities and Challenges
  4. 2.4 Mesenchymal Stem Cell Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Mesenchymal Stem Cell Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Mesenchymal Stem Cell Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Mesenchymal Stem Cell Drugs Price (2021-2026)
  4. 3.4 Global Mesenchymal Stem Cell Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Mesenchymal Stem Cell Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Mesenchymal Stem Cell Drugs Company, Product Type & Application
  7. 3.7 Global Mesenchymal Stem Cell Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Mesenchymal Stem Cell Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Mesenchymal Stem Cell Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Mesenchymal Stem Cell Drugs Tier 1, Tier 2, and Tier 3
4 Mesenchymal Stem Cell Drugs Regional Status and Outlook
  1. 4.1 Global Mesenchymal Stem Cell Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Mesenchymal Stem Cell Drugs Historic Market Size by Region
  3. 4.2.1 Global Mesenchymal Stem Cell Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Mesenchymal Stem Cell Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Mesenchymal Stem Cell Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Mesenchymal Stem Cell Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Mesenchymal Stem Cell Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Mesenchymal Stem Cell Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Mesenchymal Stem Cell Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Mesenchymal Stem Cell Drugs by Application
  1. 5.1 Mesenchymal Stem Cell Drugs Market by Application
  2. 5.1.1 Tissue Repair
  3. 5.1.2 Immunomodulation
  4. 5.2 Global Mesenchymal Stem Cell Drugs Market Size by Application
  5. 5.2.1 Global Mesenchymal Stem Cell Drugs Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Mesenchymal Stem Cell Drugs Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Mesenchymal Stem Cell Drugs Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Mesenchymal Stem Cell Drugs Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Mesenchymal Stem Cell Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Mesenchymal Stem Cell Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Mesenchymal Stem Cell Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Mesenchymal Stem Cell Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Anterogen
  2. 6.1.1 Anterogen Company Information
  3. 6.1.2 Anterogen Business Overview
  4. 6.1.3 Anterogen Mesenchymal Stem Cell Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Anterogen Mesenchymal Stem Cell Drugs Product Portfolio
  6. 6.1.5 Anterogen Recent Developments
  7. 6.2 JCR Pharmaceuticals
  8. 6.2.1 JCR Pharmaceuticals Company Information
  9. 6.2.2 JCR Pharmaceuticals Business Overview
  10. 6.2.3 JCR Pharmaceuticals Mesenchymal Stem Cell Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 JCR Pharmaceuticals Mesenchymal Stem Cell Drugs Product Portfolio
  12. 6.2.5 JCR Pharmaceuticals Recent Developments
  13. 6.3 Medipost
  14. 6.3.1 Medipost Company Information
  15. 6.3.2 Medipost Business Overview
  16. 6.3.3 Medipost Mesenchymal Stem Cell Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Medipost Mesenchymal Stem Cell Drugs Product Portfolio
  18. 6.3.5 Medipost Recent Developments
  19. 6.4 Pharmicell
  20. 6.4.1 Pharmicell Company Information
  21. 6.4.2 Pharmicell Business Overview
  22. 6.4.3 Pharmicell Mesenchymal Stem Cell Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Pharmicell Mesenchymal Stem Cell Drugs Product Portfolio
  24. 6.4.5 Pharmicell Recent Developments
  25. 6.5 Stempeutics
  26. 6.5.1 Stempeutics Company Information
  27. 6.5.2 Stempeutics Business Overview
  28. 6.5.3 Stempeutics Mesenchymal Stem Cell Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Stempeutics Mesenchymal Stem Cell Drugs Product Portfolio
  30. 6.5.5 Stempeutics Recent Developments
  31. 6.6 Osiris Therapeutics
  32. 6.6.1 Osiris Therapeutics Company Information
  33. 6.6.2 Osiris Therapeutics Business Overview
  34. 6.6.3 Osiris Therapeutics Mesenchymal Stem Cell Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Osiris Therapeutics Mesenchymal Stem Cell Drugs Product Portfolio
  36. 6.6.5 Osiris Therapeutics Recent Developments
  37. 6.7 CHIESI Farmaceutici
  38. 6.7.1 CHIESI Farmaceutici Company Information
  39. 6.7.2 CHIESI Farmaceutici Business Overview
  40. 6.7.3 CHIESI Farmaceutici Mesenchymal Stem Cell Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 CHIESI Farmaceutici Mesenchymal Stem Cell Drugs Product Portfolio
  42. 6.7.5 CHIESI Farmaceutici Recent Developments
  43. 6.8 Takeda
  44. 6.8.1 Takeda Company Information
  45. 6.8.2 Takeda Business Overview
  46. 6.8.3 Takeda Mesenchymal Stem Cell Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Takeda Mesenchymal Stem Cell Drugs Product Portfolio
  48. 6.8.5 Takeda Recent Developments
7 North America by Country
  1. 7.1 North America Mesenchymal Stem Cell Drugs Sales by Country
  2. 7.1.1 North America Mesenchymal Stem Cell Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Mesenchymal Stem Cell Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Mesenchymal Stem Cell Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Mesenchymal Stem Cell Drugs Market Size by Country
  6. 7.2.1 North America Mesenchymal Stem Cell Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Mesenchymal Stem Cell Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Mesenchymal Stem Cell Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Mesenchymal Stem Cell Drugs Sales by Country
  2. 8.1.1 Europe Mesenchymal Stem Cell Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Mesenchymal Stem Cell Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Mesenchymal Stem Cell Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Mesenchymal Stem Cell Drugs Market Size by Country
  6. 8.2.1 Europe Mesenchymal Stem Cell Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Mesenchymal Stem Cell Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Mesenchymal Stem Cell Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Mesenchymal Stem Cell Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Mesenchymal Stem Cell Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Mesenchymal Stem Cell Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Mesenchymal Stem Cell Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Mesenchymal Stem Cell Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Mesenchymal Stem Cell Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Mesenchymal Stem Cell Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Mesenchymal Stem Cell Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Mesenchymal Stem Cell Drugs Sales by Country
  2. 10.1.1 South America Mesenchymal Stem Cell Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Mesenchymal Stem Cell Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Mesenchymal Stem Cell Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Mesenchymal Stem Cell Drugs Market Size by Country
  6. 10.2.1 South America Mesenchymal Stem Cell Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Mesenchymal Stem Cell Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Mesenchymal Stem Cell Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Mesenchymal Stem Cell Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Mesenchymal Stem Cell Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Mesenchymal Stem Cell Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Mesenchymal Stem Cell Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Mesenchymal Stem Cell Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Mesenchymal Stem Cell Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Mesenchymal Stem Cell Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Mesenchymal Stem Cell Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Mesenchymal Stem Cell Drugs Value Chain Analysis
  2. 12.1.1 Mesenchymal Stem Cell Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Mesenchymal Stem Cell Drugs Production Mode & Process
  7. 12.2 Mesenchymal Stem Cell Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Mesenchymal Stem Cell Drugs Distributors
  10. 12.2.3 Mesenchymal Stem Cell Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst